Shares of CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) have been given a consensus recommendation of “Hold” by the six brokerages that are presently covering the company, Marketbeat.com reports. Six research analysts have rated the stock with a hold rating. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $117.00.
Several equities research analysts have weighed in on CHEOY shares. Royal Bank Of Canada cut CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 target price for the company. in a research note on Thursday, July 16th. Zacks Research raised CochLear from a “strong sell” rating to a “hold” rating in a report on Monday, June 22nd. Canaccord Genuity Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 18th. Finally, Jefferies Financial Group lowered CochLear from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, July 22nd.
Get Our Latest Stock Report on CochLear
CochLear Trading Down 0.2%
CochLear Company Profile
Cochlear Limited is an Australian medical device company that develops, manufactures and supplies implantable hearing solutions. Its products are designed for people with severe to profound hearing loss who may not receive sufficient benefit from conventional hearing aids.
The company’s portfolio includes cochlear implants, bone conduction hearing implants, and related sound processors, accessories, software and support services. Cochlear also provides rehabilitation resources, clinical support and ongoing product services intended to help recipients use and maintain their hearing systems.
Founded in 1981 and headquartered in Sydney, Australia, Cochlear serves customers through a global network spanning Australia, New Zealand, North America, Europe, Asia and other international markets.
Further Reading
- Five stocks we like better than CochLear
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
